Novavax, Inc.

{
  "main_header": {
    "sid": 1158341,
    "name": "Novavax, Inc.",
    "stock_name": "Novavax, Inc.",
    "full_name": "Novavax, Inc.",
    "name_url": "stocks-analysis/novavax-inc",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "8.25",
    "chg": 0.84,
    "chgp": "11.34%",
    "dir": 1,
    "prev_price": "7.41",
    "mcapval": "1,608.74",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US6700024010",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "6.5 M",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novavax-inc-1158341-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Novavax, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novavax-changes-valuation-grade-from-fair-to-risky-amid-price-decline-3686243",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NovavaxInc_valuationdot_3686243.png",
        "date": "2025-11-10 15:52:40",
        "description": "Novavax, Inc. has recently adjusted its valuation, revealing a P/E ratio of 2 and a negative price-to-book value of -16.01. The company has faced significant stock declines, with an 18.95% drop over the past year and a 91.72% decrease over five years, contrasting with broader market gains."
      },
      {
        "title": "Novavax, Inc. Experiences Evaluation Revision Amid Mixed Market Signals and Performance Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novavax-inc-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-stock-decline-3686156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NovavaxInc_technicaldot_3686156.png",
        "date": "2025-11-10 15:23:43",
        "description": "Novavax, Inc. has recently adjusted its evaluation amid fluctuating market conditions, with its stock priced at $7.44. The company has faced notable volatility over the past year, underperforming the S&P 500. Technical indicators present mixed signals, reflecting the challenges in the competitive pharmaceuticals sector."
      }
    ],
    "total": 17,
    "sid": "1158341",
    "stock_news_url": "https://www.marketsmojo.com/news/novavax-inc-1158341"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Novavax, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape

2025-11-10 15:52:40

Novavax, Inc. has recently adjusted its valuation, revealing a P/E ratio of 2 and a negative price-to-book value of -16.01. The company has faced significant stock declines, with an 18.95% drop over the past year and a 91.72% decrease over five years, contrasting with broader market gains.

Read full news article

Novavax, Inc. Experiences Evaluation Revision Amid Mixed Market Signals and Performance Challenges

2025-11-10 15:23:43

Novavax, Inc. has recently adjusted its evaluation amid fluctuating market conditions, with its stock priced at $7.44. The company has faced notable volatility over the past year, underperforming the S&P 500. Technical indicators present mixed signals, reflecting the challenges in the competitive pharmaceuticals sector.

Read full news article

View All News